ArticleOncology letters2016

Early detection of tumor relapse/regrowth by consecutive minimal residual disease monitoring in high-risk neuroblastoma patients.

Satoshi Hirase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.